What amount sold does Infinity Bio, Inc. report in Form D filings?

The latest linked filings report $11.5M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Infinity Bio, Inc.'s most recent SEC filing?

Infinity Bio, Inc.'s most recent Form D filing was on 2025-08-20.

How many investors does Infinity Bio, Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Infinity Bio, Inc. offer?

Infinity Bio, Inc.'s SEC Form D filings indicate equity offerings.

Infinity Bio, Inc.

CIK: 0001982572·Other Health Care·BALTIMORE, MD·Corporation·Founded 2023

Reported Sold

$11,516,093

Total Filings

Identified Offerings

Last Filed

Aug 20, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Aug 20, 2025Form D — New notice

Reported sold: $5,000,000 · Target: $7,000,000

Rule 506(b)·1 investor

Mar 11, 2025Form D — New notice

Reported sold: $2,000,000 · Target: $5,000,000

Rule 506(b)·2 investors

Jun 3, 2024Form D/A — Amendment

Reported sold: $4,516,093 · Target: $4,516,093

Rule 506(b)·1 investor

Changed: Reported amount sold, Offering target

Jun 26, 2023Form D — New notice

Reported sold: $2,500,000 · Target: $4,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

25%

Latest reported sold across 3 identified offerings

$11,516,093

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Caroline Popper

Related Person

Appears on 4 filings

Herman Scholtz

Related Person

Appears on 3 filings

Benjamin Larman

Related Person

Appears on 3 filings

Matthew Hellauer

Related Person

Appears on 3 filings

Joy Nassif

Related Person

Appears on 2 filings

Joy M Nassif

Related Person

Appears on 1 filing

H. Benjamin Larman

Related Person

Appears on 1 filing

Bill Campbell

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 20, 2025	New	$7,000,000	$5,000,000	1
Mar 11, 2025	New	$5,000,000	$2,000,000	2
Jun 3, 2024	Amendment	$4,516,093	$4,516,093	1
Jun 26, 2023	New	$4,000,000	$2,500,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Savannah Therapeutics, Inc

Other Health Care

Offering target: $6,000,000

Filed Sep 11, 2026